Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success

Structure Therapeutics (NASDAQ:GPCR) stock is surging today, up 60% after the biotech company reported promising results of its mid-stage trials for its weight loss pills. Indeed, after 12 weeks, patients on the treatment lost an average of 6.2% of their weight, with one-third of patients losing more than 10% of their weight. This is comparable to Eli Lilly (NYSE:LLY) oforglipron pill at roughly the same point of its study. However, this came at the cost of vomiting, which almost 66% of Structure's patients ...